Check Capital Management Inc. CA Boosts Stock Holdings in Trupanion, Inc. (NASDAQ:TRUP)

Check Capital Management Inc. CA raised its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 4.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 24,000 shares of the financial services provider’s stock after purchasing an additional 1,075 shares during the quarter. Trupanion accounts for about 0.0% of Check Capital Management Inc. CA’s holdings, making the stock its 21st biggest position. Check Capital Management Inc. CA owned approximately 0.06% of Trupanion worth $732,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in TRUP. Belpointe Asset Management LLC grew its stake in shares of Trupanion by 2,500.0% during the 1st quarter. Belpointe Asset Management LLC now owns 832 shares of the financial services provider’s stock worth $36,000 after purchasing an additional 800 shares during the period. Captrust Financial Advisors boosted its holdings in Trupanion by 162.6% during the first quarter. Captrust Financial Advisors now owns 893 shares of the financial services provider’s stock worth $80,000 after buying an additional 553 shares in the last quarter. Tower Research Capital LLC TRC grew its position in Trupanion by 128.4% during the first quarter. Tower Research Capital LLC TRC now owns 1,039 shares of the financial services provider’s stock worth $45,000 after buying an additional 584 shares during the period. BluePath Capital Management LLC purchased a new position in Trupanion in the third quarter valued at about $31,000. Finally, Point72 Hong Kong Ltd purchased a new position in Trupanion in the first quarter valued at about $153,000.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Stifel Nicolaus upped their price target on Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a report on Friday, February 16th. Piper Sandler lowered their target price on Trupanion from $32.00 to $28.00 and set a “neutral” rating on the stock in a report on Friday, April 5th. Finally, Evercore ISI cut their price target on Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a research note on Tuesday, February 20th. Four equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $33.20.

Trupanion Price Performance

Trupanion stock traded up $1.09 during mid-day trading on Friday, hitting $22.45. 932,517 shares of the company were exchanged, compared to its average volume of 682,567. Trupanion, Inc. has a 12-month low of $18.45 and a 12-month high of $37.71. The company has a market capitalization of $938.75 million, a P/E ratio of -20.79 and a beta of 1.71. The business’s 50 day simple moving average is $26.62 and its two-hundred day simple moving average is $26.96. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.63 and a quick ratio of 1.63.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Thursday, February 15th. The financial services provider reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.13. The firm had revenue of $295.50 million during the quarter, compared to analysts’ expectations of $289.84 million. Trupanion had a negative return on equity of 15.19% and a negative net margin of 4.03%. The firm’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same quarter last year, the business posted ($0.23) EPS. Analysts forecast that Trupanion, Inc. will post -0.43 earnings per share for the current fiscal year.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.